Foley Hoag Guides Organogenesis in $130M Series A Convertible Preferred Stock PIPE
November 26, 2024
November 26, 2024
BOSTON, Massachusetts, Nov. 26 -- Foley Hoag, a law firm, issued the following news:
Foley Hoag LLP advised Organogenesis Holdings Inc. (Nasdaq: ORGO) ("Organogenesis"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, in connection with its $130 million Series A Convertible Preferred Stock PIPE.
Foley Hoag attorney . . .
Foley Hoag LLP advised Organogenesis Holdings Inc. (Nasdaq: ORGO) ("Organogenesis"), a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, in connection with its $130 million Series A Convertible Preferred Stock PIPE.
Foley Hoag attorney . . .